ArticleCancer chemotherapy and pharmacology2026

In vivo evaluation of the antitumor peptide CIGB-552: antitumor activity, pharmacokinetics and safety of the subcutaneously administered peptide.

Nivaldo Angel Gómez Hernández et al.PubMed ↗Publisher ↗

No numbers read from the abstract.